AAHomecare’s comments include recommendations to keep the bid ceiling at the unadjusted 2015 fee schedule.

AAHomecare joined 66 other groups to urge CMS to streamline access to FDA-authorized breakthrough medical technology.  

If you and your company are not planning on submitting comments, please take a moment and reconsider.

While the DME industry’s focus is justifiably on competitive bidding, there are other components of the proposed rule that merit attention.

“This is an all-hands-on-deck moment,” said Tom Ryan, president and CEO of AAHomecare. “We must activate every corner of the HME community."

The Big Beautiful (Awful) Bill has already passed, and the threat to Medicaid funding is no longer theoretical.